Need professional-grade analysis? Visit stockanalysis.com
$320.98M
N/A
115
N/A
Clearpoint Neuro Inc (CLPT) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $10.72, down 9.08% from the previous close.
Over the past year, CLPT has traded between a low of $8.68 and a high of $29.60. The stock has lost 19.1% over this period. It is currently 63.8% below its 52-week high.
Clearpoint Neuro Inc has a market capitalization of $320.98M.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Side-by-side comparison against top Healthcare peers.